Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	SMARCA2 BCL9L ARID1B CAMTA2 ARID1A	1.30e-04	303	33	5	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	SMARCA2 BCL9L MED18 ARID1B CAMTA2 ARID1A	2.81e-04	562	33	6	GO:0003712
GeneOntologyMolecularFunction	racemase and epimerase activity	RENBP NAXE	3.99e-04	18	33	2	GO:0016854
GeneOntologyMolecularFunction	chromatin binding	SMARCA2 ARID1B CAMTA2 NCAPH2 REST ARID1A	1.19e-03	739	33	6	GO:0003682
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SMARCA2 NAV2 ARID1A	1.19e-03	127	33	3	GO:0008094
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	SMARCA2 ARID1A	1.70e-03	37	33	2	GO:0140658
GeneOntologyBiologicalProcess	myoblast differentiation	SMARCA2 BCL9L ARID1B REST ARID1A	2.37e-06	136	33	5	GO:0045445
GeneOntologyBiologicalProcess	regulation of nucleotide-excision repair	SMARCA2 ARID1B ARID1A	1.33e-05	29	33	3	GO:2000819
GeneOntologyBiologicalProcess	T cell differentiation	SMARCA2 CARD11 ARID1B NCAPH2 ARID1A STAT6	2.81e-05	382	33	6	GO:0030217
GeneOntologyBiologicalProcess	regulation of G0 to G1 transition	SMARCA2 ARID1B ARID1A	4.10e-05	42	33	3	GO:0070316
GeneOntologyBiologicalProcess	G0 to G1 transition	SMARCA2 ARID1B ARID1A	4.73e-05	44	33	3	GO:0045023
GeneOntologyBiologicalProcess	regulation of chromosome segregation	SMARCA2 ARID1B NCAPH2 ARID1A	6.94e-05	139	33	4	GO:0051983
GeneOntologyBiologicalProcess	positive regulation of stem cell population maintenance	SMARCA2 REST ARID1A	7.37e-05	51	33	3	GO:1902459
GeneOntologyBiologicalProcess	positive regulation of myoblast differentiation	SMARCA2 ARID1B ARID1A	8.75e-05	54	33	3	GO:0045663
GeneOntologyBiologicalProcess	lymphocyte differentiation	SMARCA2 CARD11 ARID1B NCAPH2 ARID1A STAT6	1.84e-04	537	33	6	GO:0030098
GeneOntologyBiologicalProcess	nuclear chromosome segregation	SMARCA2 ARID1B NCAPH2 ARID1A KASH5	2.38e-04	356	33	5	GO:0098813
GeneOntologyBiologicalProcess	regulation of stem cell population maintenance	SMARCA2 REST ARID1A	2.62e-04	78	33	3	GO:2000036
GeneOntologyBiologicalProcess	positive regulation of lymphocyte activation	SMARCA2 CARD11 ARID1B ARID1A STAT6	3.41e-04	385	33	5	GO:0051251
GeneOntologyBiologicalProcess	nucleotide-excision repair	SMARCA2 ARID1B ARID1A	3.73e-04	88	33	3	GO:0006289
GeneOntologyBiologicalProcess	regulation of myoblast differentiation	SMARCA2 ARID1B ARID1A	4.25e-04	92	33	3	GO:0045661
GeneOntologyBiologicalProcess	regulation of T cell differentiation	SMARCA2 CARD11 ARID1B ARID1A	4.48e-04	226	33	4	GO:0045580
GeneOntologyBiologicalProcess	regulation of mitotic metaphase/anaphase transition	SMARCA2 ARID1B ARID1A	4.67e-04	95	33	3	GO:0030071
GeneOntologyBiologicalProcess	positive regulation of double-strand break repair	SMARCA2 ARID1B ARID1A	4.67e-04	95	33	3	GO:2000781
GeneOntologyBiologicalProcess	mononuclear cell differentiation	SMARCA2 CARD11 ARID1B NCAPH2 ARID1A STAT6	4.72e-04	640	33	6	GO:1903131
GeneOntologyBiologicalProcess	regulation of metaphase/anaphase transition of cell cycle	SMARCA2 ARID1B ARID1A	5.12e-04	98	33	3	GO:1902099
GeneOntologyBiologicalProcess	positive regulation of leukocyte activation	SMARCA2 CARD11 ARID1B ARID1A STAT6	5.24e-04	423	33	5	GO:0002696
GeneOntologyBiologicalProcess	stem cell population maintenance	SMARCA2 BCL9L REST ARID1A	5.35e-04	237	33	4	GO:0019827
GeneOntologyBiologicalProcess	metaphase/anaphase transition of mitotic cell cycle	SMARCA2 ARID1B ARID1A	5.43e-04	100	33	3	GO:0007091
GeneOntologyBiologicalProcess	maintenance of cell number	SMARCA2 BCL9L REST ARID1A	5.79e-04	242	33	4	GO:0098727
GeneOntologyBiologicalProcess	metaphase/anaphase transition of cell cycle	SMARCA2 ARID1B ARID1A	5.92e-04	103	33	3	GO:0044784
GeneOntologyBiologicalProcess	chromosome organization	SMARCA2 NAV2 ARID1B NCAPH2 ARID1A KASH5	6.81e-04	686	33	6	GO:0051276
GeneOntologyBiologicalProcess	positive regulation of cell activation	SMARCA2 CARD11 ARID1B ARID1A STAT6	6.86e-04	449	33	5	GO:0050867
GeneOntologyBiologicalProcess	sister chromatid segregation	SMARCA2 ARID1B NCAPH2 ARID1A	6.94e-04	254	33	4	GO:0000819
GeneOntologyBiologicalProcess	regulation of sister chromatid segregation	SMARCA2 ARID1B ARID1A	7.36e-04	111	33	3	GO:0033045
GeneOntologyBiologicalProcess	T cell activation	SMARCA2 CARD11 ARID1B NCAPH2 ARID1A STAT6	7.62e-04	701	33	6	GO:0042110
GeneOntologyBiologicalProcess	chromosome segregation	SMARCA2 ARID1B NCAPH2 ARID1A KASH5	8.03e-04	465	33	5	GO:0007059
GeneOntologyBiologicalProcess	regulation of lymphocyte differentiation	SMARCA2 CARD11 ARID1B ARID1A	8.24e-04	266	33	4	GO:0045619
GeneOntologyBiologicalProcess	regulation of chromosome organization	SMARCA2 ARID1B NCAPH2 ARID1A	8.24e-04	266	33	4	GO:0033044
GeneOntologyBiologicalProcess	positive regulation of T cell activation	SMARCA2 CARD11 ARID1B ARID1A	1.14e-03	290	33	4	GO:0050870
GeneOntologyBiologicalProcess	leukocyte differentiation	SMARCA2 CARD11 ARID1B NCAPH2 ARID1A STAT6	1.41e-03	789	33	6	GO:0002521
GeneOntologyBiologicalProcess	regulation of cell development	SMARCA2 DIP2B CARD11 ARID1B REST SEMA6D ARID1A	1.48e-03	1095	33	7	GO:0060284
GeneOntologyBiologicalProcess	positive regulation of DNA repair	SMARCA2 ARID1B ARID1A	1.53e-03	143	33	3	GO:0045739
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	SMARCA2 ARID1B ARID1A	1.56e-03	144	33	3	GO:0045582
GeneOntologyBiologicalProcess	positive regulation of leukocyte cell-cell adhesion	SMARCA2 CARD11 ARID1B ARID1A	1.58e-03	317	33	4	GO:1903039
GeneOntologyBiologicalProcess	regulation of double-strand break repair	SMARCA2 ARID1B ARID1A	1.62e-03	146	33	3	GO:2000779
GeneOntologyBiologicalProcess	negative regulation of axon extension	DIP2B SEMA6D	1.68e-03	38	33	2	GO:0030517
GeneOntologyBiologicalProcess	double-strand break repair	SMARCA2 ARID1B ARID1A KASH5	1.71e-03	324	33	4	GO:0006302
GeneOntologyBiologicalProcess	cellular response to angiotensin	AHCYL1 ARID1B	1.86e-03	40	33	2	GO:1904385
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	SMARCA2 ARID1B ARID1A STAT6	1.89e-03	333	33	4	GO:0051054
GeneOntologyBiologicalProcess	positive regulation of lymphocyte differentiation	SMARCA2 ARID1B ARID1A	2.18e-03	162	33	3	GO:0045621
GeneOntologyCellularComponent	bBAF complex	SMARCA2 ARID1B ARID1A	4.27e-07	10	33	3	GO:0140092
GeneOntologyCellularComponent	npBAF complex	SMARCA2 ARID1B ARID1A	1.29e-06	14	33	3	GO:0071564
GeneOntologyCellularComponent	brahma complex	SMARCA2 ARID1B ARID1A	1.29e-06	14	33	3	GO:0035060
GeneOntologyCellularComponent	nBAF complex	SMARCA2 ARID1B ARID1A	1.98e-06	16	33	3	GO:0071565
GeneOntologyCellularComponent	SWI/SNF complex	SMARCA2 ARID1B ARID1A	1.41e-05	30	33	3	GO:0016514
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	SMARCA2 ARID1B ARID1A	4.63e-04	96	33	3	GO:0070603
GeneOntologyCellularComponent	ATPase complex	SMARCA2 ARID1B ARID1A	1.09e-03	129	33	3	GO:1904949
HumanPheno	Wide nasal base	SMARCA2 ARID1B ARID1A	1.74e-05	28	10	3	HP:0012810
HumanPheno	Abnormal nasal base norphology	SMARCA2 ARID1B ARID1A	2.15e-05	30	10	3	HP:0012808
HumanPheno	Thick nasal alae	SMARCA2 ARID1B ARID1A	4.80e-05	39	10	3	HP:0009928
HumanPheno	Prominent interphalangeal joints	SMARCA2 ARID1B	5.18e-05	6	10	2	HP:0006237
HumanPheno	Broad philtrum	SMARCA2 ARID1B ARID1A	7.41e-05	45	10	3	HP:0000289
HumanPheno	Neoplasm of the liver	ARID1B REST ARID1A STAT6	1.01e-04	140	10	4	HP:0002896
HumanPheno	Gastrointestinal eosinophilia	CARD11 STAT6	3.12e-04	14	10	2	HP:0032064
HumanPheno	Hypoplastic fifth fingernail	ARID1B ARID1A	3.12e-04	14	10	2	HP:0008398
Domain	BAF250_C	ARID1B ARID1A	2.49e-06	2	30	2	IPR033388
Domain	BAF250_C	ARID1B ARID1A	2.49e-06	2	30	2	PF12031
Domain	BAF250/Osa	ARID1B ARID1A	2.49e-06	2	30	2	IPR021906
Domain	-	ARID1B ARID1A	2.59e-04	15	30	2	1.10.150.60
Domain	ARID	ARID1B ARID1A	2.59e-04	15	30	2	PF01388
Domain	BRIGHT	ARID1B ARID1A	2.59e-04	15	30	2	SM00501
Domain	ARID_dom	ARID1B ARID1A	2.59e-04	15	30	2	IPR001606
Domain	ARID	ARID1B ARID1A	2.59e-04	15	30	2	PS51011
Pathway	WP_KLEEFSTRA_SYNDROME	SMARCA2 ARID1B ARID1A	1.17e-05	29	22	3	M48076
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	SMARCA2 ARID1B ARID1A	2.09e-05	35	22	3	M47969
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	SMARCA2 ARID1B ARID1A	2.48e-05	37	22	3	M27797
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	SMARCA2 ARID1B ARID1A	3.64e-05	42	22	3	M48237
Pathway	REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	SMARCA2 ARID1B ARID1A	2.33e-04	78	22	3	M27234
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	SMARCA2 ARID1B ARID1A	4.16e-04	95	22	3	M48268
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	SMARCA2 ARID1B ARID1A	4.42e-04	97	22	3	M48262
Pathway	WP_THERMOGENESIS	SMARCA2 ARID1B ARID1A	6.06e-04	108	22	3	M39746
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	SMARCA2 ARID1B REST ARID1A	7.54e-04	272	22	4	M29619
Pathway	WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1	ARID1B ARID1A	1.05e-03	31	22	2	M39522
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	SMARCA2 ARID1B ARID1A	1.21e-03	137	22	3	M48232
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	SMARCA2 ARID1B ARID1A	1.34e-03	142	22	3	M48257
Pubmed	Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors.	SMARCA2 ARID1B ARID1A	7.77e-09	5	33	3	12200431
Pubmed	REST repression of neuronal genes requires components of the hSWI.SNF complex.	SMARCA2 ARID1B REST ARID1A	1.35e-08	28	33	4	12192000
Pubmed	The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.	SMARCA2 ARID1B ARID1A	1.55e-08	6	33	3	16230384
Pubmed	Numerous BAF complex genes are mutated in Coffin-Siris syndrome.	SMARCA2 ARID1B ARID1A	1.55e-08	6	33	3	25081545
Pubmed	ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.	SMARCA2 ARID1B ARID1A	9.30e-08	10	33	3	23129809
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	SMARCA2 ARID1B ARID1A	1.70e-07	12	33	3	11734557
Pubmed	Separation and Quantification of Some Alkaloids from Fumaria parviflora by Capillary Isotachophoresis1.	SMARCA2 ARID1B ARID1A	2.21e-07	13	33	3	17340523
Pubmed	The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling.	SMARCA2 MED18 ARID1B ARID1A	2.21e-07	55	33	4	35945219
Pubmed	Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation.	SMARCA2 ARID1B ARID1A	3.51e-07	15	33	3	11175787
Pubmed	Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.	SMARCA2 ARID1B ARID1A	3.51e-07	15	33	3	17255939
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	SMARCA2 ARID1B ARID1A	3.51e-07	15	33	3	23785148
Pubmed	Regulation of dendritic development by neuron-specific chromatin remodeling complexes.	SMARCA2 ARID1B ARID1A	3.51e-07	15	33	3	17920018
Pubmed	The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.	SMARCA2 ARID1B ARID1A	3.51e-07	15	33	3	11263494
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	SMARCA2 ARID1B ARID1A	5.24e-07	17	33	3	12368262
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	SMARCA2 ARID1B ARID1A	5.24e-07	17	33	3	11078522
Pubmed	BAF complexes facilitate decatenation of DNA by topoisomerase IIα.	SMARCA2 ARID1B ARID1A	6.29e-07	18	33	3	23698369
Pubmed	Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.	SMARCA2 ARID1B ARID1A	7.46e-07	19	33	3	12110891
Pubmed	Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction.	SMARCA2 ARID1B ARID1A	7.46e-07	19	33	3	16932743
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1B ARID1A	8.73e-07	2	33	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1B ARID1A	8.73e-07	2	33	2	32791957
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1B ARID1A	8.73e-07	2	33	2	34386776
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1B ARID1A	8.73e-07	2	33	2	29890703
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1B ARID1A	8.73e-07	2	33	2	23202128
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1B ARID1A	8.73e-07	2	33	2	33890484
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1B ARID1A	8.73e-07	2	33	2	24788099
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1B ARID1A	8.73e-07	2	33	2	28967863
Pubmed	Characterization of mammalian orthologues of the Drosophila osa gene: cDNA cloning, expression, chromosomal localization, and direct physical interaction with Brahma chromatin-remodeling complex.	SMARCA2 ARID1A	8.73e-07	2	33	2	11318604
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1B ARID1A	8.73e-07	2	33	2	33052929
Pubmed	SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.	SMARCA2 REST	8.73e-07	2	33	2	20457675
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1B ARID1A	8.73e-07	2	33	2	24562383
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1B ARID1A	8.73e-07	2	33	2	27562491
Pubmed	Diversity and specialization of mammalian SWI/SNF complexes.	SMARCA2 ARID1B ARID1A	1.36e-06	23	33	3	8804307
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	SMARCA2 ARID1B ARID1A	1.36e-06	23	33	3	30962207
Pubmed	The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle.	SMARCA2 ARID1B ARID1A	1.55e-06	24	33	3	12215535
Pubmed	SWI/SNF chromatin remodeling and cancer.	SMARCA2 ARID1B ARID1A	1.55e-06	24	33	3	11790558
Pubmed	Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.	SMARCA2 ARID1B ARID1A	1.55e-06	24	33	3	10078207
Pubmed	Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.	SMARCA2 ARID1B ARID1A	1.99e-06	26	33	3	10778858
Pubmed	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	SMARCA2 ARID1B ARID1A	2.24e-06	27	33	3	29374058
Pubmed	Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.	ARID1B ARID1A	2.62e-06	3	33	2	33432679
Pubmed	Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.	SMARCA2 ARID1A	2.62e-06	3	33	2	36464671
Pubmed	Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.	ARID1B ARID1A	2.62e-06	3	33	2	21647563
Pubmed	Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.	ARID1B ARID1A	2.62e-06	3	33	2	22426308
Pubmed	Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.	ARID1B ARID1A	2.62e-06	3	33	2	24382590
Pubmed	TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.	ARID1B ARID1A	2.62e-06	3	33	2	34044070
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1B ARID1A	2.62e-06	3	33	2	26716708
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1B ARID1A	2.62e-06	3	33	2	34512623
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	SMARCA2 ARID1B ARID1A	2.80e-06	29	33	3	19279220
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	SMARCA2 ARID1B ARID1A	2.80e-06	29	33	3	36800290
Pubmed	The core SWI/SNF catalytic subunit Brg1 regulates nephron progenitor cell proliferation and differentiation.	SMARCA2 ARID1B ARID1A	4.99e-06	35	33	3	32504627
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	SMARCA2 BCL9L MED18 ARID1B ARID1A	5.21e-06	268	33	5	33640491
Pubmed	Dual role of NRSF/REST in activation and repression of the glucocorticoid response.	SMARCA2 REST	5.23e-06	4	33	2	17984088
Pubmed	Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.	SMARCA2 ARID1A	5.23e-06	4	33	2	31906887
Pubmed	Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.	ARID1B ARID1A	5.23e-06	4	33	2	28863077
Pubmed	Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma.	SMARCA2 ARID1A	5.23e-06	4	33	2	28296015
Pubmed	Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.	ARID1B ARID1A	5.23e-06	4	33	2	15170388
Pubmed	Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.	ARID1B ARID1A	5.23e-06	4	33	2	11988099
Pubmed	The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.	SMARCA2 ARID1A	5.23e-06	4	33	2	33481850
Pubmed	Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation.	SMARCA2 ARID1B ARID1A	5.92e-06	37	33	3	24335282
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	SMARCA2 ARID1B ARID1A	7.51e-06	40	33	3	34585037
Pubmed	Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations.	ARID1B ARID1A	8.72e-06	5	33	2	38489371
Pubmed	Recent advances in understanding chromatin remodeling by Swi/Snf complexes.	ARID1B ARID1A	8.72e-06	5	33	2	12672490
Pubmed	Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex.	SMARCA2 ARID1A	1.31e-05	6	33	2	16940996
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SMARCA2 ARID1B REST ARID1A	1.48e-05	157	33	4	30186101
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SMARCA2 ARID1B ARID1A	1.48e-05	50	33	3	27716508
Pubmed	Widespread macromolecular interaction perturbations in human genetic disorders.	SMARCA2 NAV2 AHCYL1 NCAPH2 KASH5 PSD4	1.74e-05	590	33	6	25910212
Pubmed	Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.	ARID1B ARID1A	1.83e-05	7	33	2	23540691
Pubmed	Interaction network of human early embryonic transcription factors.	SMARCA2 BCL9L AHCYL1 ARID1B ARID1A	1.91e-05	351	33	5	38297188
Pubmed	Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.	SMARCA2 ARID1A	2.44e-05	8	33	2	26986003
Pubmed	A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.	SMARCA2 ARID1B ARID1A	2.70e-05	61	33	3	20305087
Pubmed	Coffin-Siris Syndrome	ARID1B ARID1A	3.13e-05	9	33	2	23556151
Pubmed	Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.	ARID1B ARID1A	3.13e-05	9	33	2	20086098
Pubmed	The BAF chromatin complex component SMARCC1 does not mediate GLI transcriptional repression of Hedgehog target genes in limb buds.	ARID1B ARID1A	3.13e-05	9	33	2	37805104
Pubmed	Genome-wide association study of sensory disturbances in the inferior alveolar nerve after bilateral sagittal split ramus osteotomy.	ARID1B STAT6	3.13e-05	9	33	2	23834954
Pubmed	Loss of BAF (mSWI/SNF) Complexes Causes Global Transcriptional and Chromatin State Changes in Forebrain Development.	SMARCA2 ARID1B ARID1A	3.27e-05	65	33	3	26655900
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	SMARCA2 MED18 ARID1B	3.42e-05	66	33	3	23275444
Pubmed	Nomenclature of the ARID family of DNA-binding proteins.	ARID1B ARID1A	3.91e-05	10	33	2	15922553
Pubmed	Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.	ARID1B ARID1A	3.91e-05	10	33	2	12665591
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	SMARCA2 USP34 ARID1B ARID1A	5.52e-05	220	33	4	35785414
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	SMARCA2 ARID1B ARID1A	5.64e-05	78	33	3	28611094
Pubmed	Arid1a regulates bladder urothelium formation and maintenance.	ARID1B ARID1A	5.73e-05	12	33	2	35283102
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	USP34 MED18 ARID1B ARID1A PPM1G	6.44e-05	453	33	5	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	SMARCA2 USP34 BCL9L ARID1B ARID1A	6.71e-05	457	33	5	32344865
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	SMARCA2 ARID1B ARID1A	6.79e-05	83	33	3	28794006
Pubmed	Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.	SMARCA2 ARID1A	7.89e-05	14	33	2	8895581
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	SMARCA2 ARID1B	7.89e-05	14	33	2	36289231
Pubmed	An essential switch in subunit composition of a chromatin remodeling complex during neural development.	SMARCA2 ARID1A	9.10e-05	15	33	2	17640523
Pubmed	Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.	SMARCA2 ARID1A	1.04e-04	16	33	2	35390516
Pubmed	A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development.	SMARCA2 ARID1A	1.18e-04	17	33	2	16287714
Pubmed	mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.	SMARCA2 ARID1A	1.32e-04	18	33	2	14559996
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	SMARCA2 ARID1A	1.32e-04	18	33	2	28068325
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SMARCA2 USP34 AHCYL1 ARID1A	1.44e-04	282	33	4	23667531
Pubmed	Loss of BAF Complex in Developing Cortex Perturbs Radial Neuronal Migration in a WNT Signaling-Dependent Manner.	SMARCA2 ARID1B	1.64e-04	20	33	2	34220450
Pubmed	Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway.	SMARCA2 ARID1A	1.81e-04	21	33	2	20460684
Pubmed	KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.	COL4A1 SEMA6D	2.18e-04	23	33	2	28164238
Pubmed	Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation.	ARID1B ARID1A	2.38e-04	24	33	2	37543677
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	NAV2 USP34 CPHXL ARID1A	2.50e-04	326	33	4	17015433
Pubmed	A protein interaction landscape of breast cancer.	SMARCA2 NAV2 ARID1B ARID1A PPM1G	3.08e-04	634	33	5	34591612
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	ARID1B ARID1A	3.25e-04	28	33	2	30037996
Pubmed	Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.	ARID1B ARID1A	3.74e-04	30	33	2	31043422
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	SMARCA2 ARID1B ARID1A	7.30e-04	186	33	3	33637726
Interaction	SRXN1 interactions	USP34 AHCYL1 PPM1G STAT6	1.24e-06	51	32	4	int:SRXN1
Interaction	MTMR4 interactions	DIP2B MED18 AHCYL1 NCAPH2 REST	4.72e-06	158	32	5	int:MTMR4
Interaction	IRF4 interactions	SMARCA2 ARID1B ARID1A STAT6	9.68e-06	85	32	4	int:IRF4
Interaction	TBR1 interactions	SMARCA2 BCL9L ARID1B ARID1A	2.99e-05	113	32	4	int:TBR1
Interaction	ETS1 interactions	SMARCA2 ARID1B ARID1A STAT6	3.90e-05	121	32	4	int:ETS1
Interaction	SH3TC1 interactions	SMARCA2 SH3TC1	5.10e-05	7	32	2	int:SH3TC1
Interaction	PAX9 interactions	SMARCA2 BCL9L ARID1B ARID1A	5.17e-05	130	32	4	int:PAX9
Interaction	FLI1 interactions	SMARCA2 ARID1B ARID1A	1.29e-04	62	32	3	int:FLI1
Interaction	LHX4 interactions	SMARCA2 BCL9L ARID1B ARID1A	1.33e-04	166	32	4	int:LHX4
Interaction	EGR2 interactions	SMARCA2 BCL9L ARID1B ARID1A	1.49e-04	171	32	4	int:EGR2
Interaction	BICRA interactions	SMARCA2 ARID1B ARID1A	1.63e-04	67	32	3	int:BICRA
Interaction	SULT1A1 interactions	USP34 AHCYL1 PPM1G	1.63e-04	67	32	3	int:SULT1A1
Interaction	TLX1 interactions	SMARCA2 AHCYL1 ARID1B ARID1A	1.63e-04	175	32	4	int:TLX1
Interaction	GCM1 interactions	SMARCA2 ARID1B ARID1A	1.70e-04	68	32	3	int:GCM1
Interaction	ETV4 interactions	SMARCA2 ARID1B ARID1A	1.77e-04	69	32	3	int:ETV4
Interaction	LHX2 interactions	SMARCA2 BCL9L ARID1B ARID1A	1.94e-04	183	32	4	int:LHX2
Interaction	SS18L2 interactions	SMARCA2 ARID1B ARID1A	2.36e-04	76	32	3	int:SS18L2
Interaction	ADNP interactions	SMARCA2 NCAPH2 REST ARID1A	2.67e-04	199	32	4	int:ADNP
Interaction	TLE3 interactions	BCL9L AHCYL1 ARID1B ARID1A PPM1G	2.93e-04	376	32	5	int:TLE3
Interaction	SOX7 interactions	SMARCA2 ARID1B ARID1A	2.96e-04	82	32	3	int:SOX7
Interaction	IRF1 interactions	SMARCA2 ARID1B ARID1A	3.07e-04	83	32	3	int:IRF1
Interaction	STK11IP interactions	SMARCA2 ARID1B ARID1A	3.07e-04	83	32	3	int:STK11IP
Interaction	STAT6 interactions	AHCYL1 PPM1G STAT6	3.52e-04	87	32	3	int:STAT6
Interaction	SS18 interactions	SMARCA2 ARID1B ARID1A	3.64e-04	88	32	3	int:SS18
Interaction	UBE2C interactions	USP34 AHCYL1 PPM1G	4.02e-04	91	32	3	int:UBE2C
Interaction	FOXI1 interactions	SMARCA2 ARID1B ARID1A	4.15e-04	92	32	3	int:FOXI1
Interaction	SOX10 interactions	SMARCA2 ARID1B ARID1A	4.15e-04	92	32	3	int:SOX10
Interaction	BCL7B interactions	SMARCA2 ARID1B ARID1A	4.56e-04	95	32	3	int:BCL7B
Interaction	SOX17 interactions	SMARCA2 ARID1B ARID1A	4.56e-04	95	32	3	int:SOX17
Interaction	DPF3 interactions	SMARCA2 ARID1B ARID1A	4.56e-04	95	32	3	int:DPF3
Interaction	DPF1 interactions	SMARCA2 ARID1B ARID1A	4.56e-04	95	32	3	int:DPF1
Interaction	TEX13B interactions	ARID1B ARID1A	4.56e-04	20	32	2	int:TEX13B
Interaction	STMN2 interactions	AHCYL1 REST PPM1G	4.84e-04	97	32	3	int:STMN2
Interaction	SOX9 interactions	SMARCA2 ARID1B ARID1A	4.84e-04	97	32	3	int:SOX9
Interaction	SS18L1 interactions	SMARCA2 ARID1B ARID1A	4.99e-04	98	32	3	int:SS18L1
Interaction	NUP35 interactions	SMARCA2 USP34 BCL9L ARID1B ARID1A	5.07e-04	424	32	5	int:NUP35
Interaction	LHX1 interactions	SMARCA2 ARID1B ARID1A	5.77e-04	103	32	3	int:LHX1
Interaction	SMARCD3 interactions	SMARCA2 ARID1B ARID1A	6.45e-04	107	32	3	int:SMARCD3
Interaction	CRX interactions	SMARCA2 BCL9L ARID1B ARID1A	6.71e-04	254	32	4	int:CRX
Interaction	PAX8 interactions	SMARCA2 ARID1B ARID1A	7.18e-04	111	32	3	int:PAX8
Interaction	SMARCA4 interactions	SMARCA2 ARID1B REST ARID1A STAT6	7.48e-04	462	32	5	int:SMARCA4
Interaction	AR interactions	SMARCA2 USP34 BCL9L MED18 AHCYL1 ARID1B ARID1A	7.82e-04	992	32	7	int:AR
Interaction	BCL7C interactions	SMARCA2 ARID1B ARID1A	7.96e-04	115	32	3	int:BCL7C
Interaction	TBXT interactions	SMARCA2 ARID1B ARID1A	8.16e-04	116	32	3	int:TBXT
Interaction	BRD9 interactions	SMARCA2 ARID1B ARID1A	8.37e-04	117	32	3	int:BRD9
Interaction	NANOG interactions	SMARCA2 USP34 ARID1B REST ARID1A	8.97e-04	481	32	5	int:NANOG
Interaction	DDIT3 interactions	SMARCA2 ARID1B ARID1A	9.00e-04	120	32	3	int:DDIT3
Interaction	FTCD interactions	USP34 KASH5	9.65e-04	29	32	2	int:FTCD
Interaction	MLLT1 interactions	SMARCA2 ARID1B ARID1A	9.67e-04	123	32	3	int:MLLT1
Interaction	BCL7A interactions	SMARCA2 ARID1B ARID1A	9.67e-04	123	32	3	int:BCL7A
Interaction	PAX7 interactions	SMARCA2 ARID1B ARID1A	9.90e-04	124	32	3	int:PAX7
Interaction	RNF138 interactions	SMARCA2 ARID1B ARID1A	1.01e-03	125	32	3	int:RNF138
Interaction	SMARCE1 interactions	SMARCA2 ARID1B REST ARID1A	1.06e-03	287	32	4	int:SMARCE1
Interaction	TLX3 interactions	SMARCA2 BCL9L ARID1B ARID1A	1.11e-03	291	32	4	int:TLX3
Cytoband	1p35.3	MED18 ARID1A	2.77e-04	34	33	2	1p35.3
Cytoband	2q13	SH3RF3 PSD4	1.11e-03	68	33	2	2q13
Cytoband	11q23.3	ARHGEF12 BCL9L	1.45e-03	78	33	2	11q23.3
GeneFamily	AT-rich interaction domain containing	ARID1B ARID1A	1.21e-04	15	20	2	418
Coexpression	PARENT_MTOR_SIGNALING_UP	SMARCA2 USP34 MED18 AHCYL1 NCAPH2 PSD4	5.60e-05	567	32	6	M16909
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL	COL4A1 SMARCA2 USP34 REST	8.72e-05	193	32	4	M6813
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL	COL4A1 SMARCA2 USP34 REST	9.25e-05	196	32	4	MM667
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	ARHGEF12 RENBP REST PSD4	9.62e-05	198	32	4	M8379
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	SMARCA2 REST ARID1A NAXE	1.00e-04	200	32	4	M9505
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN	USP34 DIP2B REST NAXE	1.00e-04	200	32	4	M9827
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 NAV2 SEMA6D SH3RF3	1.03e-05	185	33	4	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12 SEMA6D	1.24e-05	194	33	4	1b382508453c5b08fb617f626b230adf3b6cff99
ToppCell	TCGA-Uvea\|World / Sample_Type by Project: Shred V9	CRTAC1 AHRR RENBP	1.53e-04	141	33	3	015451a83087f2705d3315ebc8f23797c6f10ed6
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	ZNF517 METTL15 CCDC157	2.31e-04	162	33	3	22b2a32217d357146c117e618813d451510a1801
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL4A1 NAV2 ARHGEF12	2.66e-04	170	33	3	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Skin-nan-24m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRTAC1 CARD11 SEMA6D	2.85e-04	174	33	3	6863222bec844f40c0c80f5c82a8ff51d1a56d0a
ToppCell	facs-Skin-nan-24m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRTAC1 CARD11 SEMA6D	2.85e-04	174	33	3	d570eab215f8287362084e37f35672e20aa0f7a2
ToppCell	facs-Skin-nan-24m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRTAC1 CARD11 SEMA6D	2.85e-04	174	33	3	5739c1b8d643ad360ef32049832d749c530ca603
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 CRTAC1	3.04e-04	178	33	3	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A1 NAV2 SH3TC1	3.15e-04	180	33	3	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 SEMA6D SH3RF3	3.15e-04	180	33	3	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAV2 CRTAC1 SEMA6D	3.15e-04	180	33	3	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	COL4A1 ARHGEF12 SH3RF3	3.20e-04	181	33	3	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	COL4A1 ARHGEF12 SH3RF3	3.20e-04	181	33	3	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 SEMA6D SH3RF3	3.25e-04	182	33	3	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CARD11 AHRR RENBP	3.25e-04	182	33	3	57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL4A1 NAV2 SEMA6D	3.30e-04	183	33	3	e84539978ab4de42e19186aed00f24bb50cbc21f
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 AHRR SEMA6D	3.41e-04	185	33	3	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.46e-04	186	33	3	77592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NAV2 CARD11 SH3RF3	3.52e-04	187	33	3	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 SEMA6D SH3RF3	3.52e-04	187	33	3	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A1 NAV2 SH3RF3	3.52e-04	187	33	3	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 AHRR SEMA6D	3.52e-04	187	33	3	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.57e-04	188	33	3	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 NAV2 SEMA6D	3.57e-04	188	33	3	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.57e-04	188	33	3	4544552ebd67e9eb3e40d8511bb2b03a6e1178f8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.57e-04	188	33	3	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	IPF-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	COL4A1 ARHGEF12 SH3RF3	3.63e-04	189	33	3	ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.63e-04	189	33	3	222e67d3fd106c43b0cae6538dddeaa7be1f759f
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	COL4A1 SEMA6D SH3RF3	3.63e-04	189	33	3	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	3.63e-04	189	33	3	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	COL4A1 ARHGEF12 SEMA6D	3.63e-04	189	33	3	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.68e-04	190	33	3	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.68e-04	190	33	3	2f54da2bee411f8868348a4c37034184b8f58a89
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL4A1 CRTAC1 SEMA6D	3.68e-04	190	33	3	59720dfe9de1b980807644536c919d2a02ba69dd
ToppCell	IPF-Endothelial-VE_Capillary_A\|IPF / Disease state, Lineage and Cell class	COL4A1 ARHGEF12 SH3RF3	3.68e-04	190	33	3	b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	3.74e-04	191	33	3	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	3.74e-04	191	33	3	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	3.74e-04	191	33	3	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 SH3TC1 SH3RF3	3.80e-04	192	33	3	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 SEMA6D SH3TC1	3.80e-04	192	33	3	d525f7f088a53110912600a7c9f6d33b9270d534
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 SEMA6D SH3TC1	3.80e-04	192	33	3	2bfac6b3956265205ca47d06888851ed68b65999
ToppCell	Fibroblasts-CD55+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL4A1 CRTAC1 SEMA6D	3.86e-04	193	33	3	8f4bf9a2fbedae35432dad96730b00c70185874c
ToppCell	PND10-Endothelial-Endothelial_blood-vessel\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.86e-04	193	33	3	1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCell	critical-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	COL4A1 NAV2 CRTAC1	3.86e-04	193	33	3	6be11fef87af04ee7a3cc223882ccd4077caded9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 DIP2B ARID1A	3.86e-04	193	33	3	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.86e-04	193	33	3	097a244cf37ce6c1ace9bae56beb7de59442cd6b
ToppCell	PND10-Endothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.86e-04	193	33	3	f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A1 ARHGEF12 SH3RF3	3.86e-04	193	33	3	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	PND14-Endothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	cee89d4340738f09d07a159cd6aeee4300776988
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	6115c20ffe414378508f3879e67815b6062341a7
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 SEMA6D SH3TC1	3.92e-04	194	33	3	c8b9551b93a5aed62154b487db90130604a6125c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	8deeb3e00237e3d9ad5a1457cd0061576421b9e9
ToppCell	PND14-Endothelial-Endothelial_blood-vessel\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	32962060d80f3edffbe9f0ecad3000c3a9817865
ToppCell	PND28-Endothelial-Endothelial_blood-vessel\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	6317e9cdf96eb020f84d50bf41f803db5c9c04a0
ToppCell	PND28-Endothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	b592c713204db7ae2f34a54f2d03d13834593c57
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	b81801fb16e8bd0d6083fe32866051d3c60f3dc7
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A1 SMARCA2 ARHGEF12	3.92e-04	194	33	3	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 AHCYL1 SEMA6D	3.97e-04	195	33	3	3123e02d2894c83962ba402085b5e6422ebf8c73
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A1 NAV2 SH3RF3	3.97e-04	195	33	3	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A1 SMARCA2 ARHGEF12	3.97e-04	195	33	3	cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARHGEF12 AHCYL1	4.03e-04	196	33	3	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARHGEF12 AHCYL1	4.03e-04	196	33	3	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 AHCYL1 SEMA6D	4.03e-04	196	33	3	1bfc3c85ce9501f52a912e53cbded7de74572b9d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 ARHGEF12 AHCYL1	4.03e-04	196	33	3	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A1 NAV2 ARID1B	4.03e-04	196	33	3	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	4.09e-04	197	33	3	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	4.09e-04	197	33	3	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A1 NAV2 SH3RF3	4.09e-04	197	33	3	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NAV2 CRTAC1 SEMA6D	4.16e-04	198	33	3	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SMARCA2 CARD11 ZNF772	4.16e-04	198	33	3	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NAV2 CRTAC1 SEMA6D	4.16e-04	198	33	3	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NAV2 CRTAC1 SEMA6D	4.16e-04	198	33	3	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	ASK428-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	COL4A1 NAV2 SEMA6D	4.16e-04	198	33	3	0047a9ef7684230ac5179efea94461480e90bdaf
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NAV2 AHRR FER1L4	4.22e-04	199	33	3	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	USP34 DIP2B ARID1B	4.22e-04	199	33	3	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	SMARCA2 ARHGEF12 REST	4.22e-04	199	33	3	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	SMARCA2 SEMA6D SH3RF3	4.22e-04	199	33	3	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	COL4A1 AHCYL1 ARID1A	4.22e-04	199	33	3	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	COL4A1 NAV2 SH3RF3	4.22e-04	199	33	3	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NAV2 SH3RF3	4.28e-04	200	33	3	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL4A1 CRTAC1 SEMA6D	4.28e-04	200	33	3	ca5401b76ab014080914bf78042d368cf318effa
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A1 ARHGEF12 USP34	4.28e-04	200	33	3	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL4A1 CRTAC1 SEMA6D	4.28e-04	200	33	3	40286010bd17cf9e34ecd5440953b072ebfae208
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	SH3TC1 STAT6 PSD4	4.28e-04	200	33	3	5c638c80661017c85f9390f1b398ac7728c8f001
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	SH3TC1 STAT6 PSD4	4.28e-04	200	33	3	604a88633d4162337e394155c7346dbdef8b9f5a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A1 SMARCA2 ARHGEF12	4.28e-04	200	33	3	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	ARHGEF12 CARD11 PSD4	4.28e-04	200	33	3	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A1 SMARCA2 ARHGEF12	4.28e-04	200	33	3	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NAV2 SH3TC1 STAT6	4.28e-04	200	33	3	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NAV2 SH3TC1 STAT6	4.28e-04	200	33	3	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A1 SMARCA2 ARHGEF12	4.28e-04	200	33	3	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL4A1 CRTAC1 SEMA6D	4.28e-04	200	33	3	70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NAV2 SH3RF3	4.28e-04	200	33	3	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A1 CARD11 SEMA6D	4.28e-04	200	33	3	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAV2 AHRR SH3RF3	4.28e-04	200	33	3	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	NAV2 ZNF772 ZNF282	4.28e-04	200	33	3	a3fcd901cb281920f1bafdfd676399a6dc37355e
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	AHRR PSD4	7.02e-04	53	33	2	d55030028f9ac970afb343ef6e1c41ab4bb2ae53
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	USP34 MED18 REST ARID1A PPM1G STAT6	2.92e-07	197	32	6	2812_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	COL4A1 ARHGEF12 CAMTA2 NCAPH2 REST ZNF282	2.92e-07	197	32	6	1803_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	SMARCA2 MED18 NCAPH2 REST SH3TC1 PSD4	2.92e-07	197	32	6	3750_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	SMARCA2 USP34 MED18 NCAPH2 REST	6.77e-06	192	32	5	3252_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SMARCA2 USP34 MED18 NCAPH2 PSD4	6.95e-06	193	32	5	3258_DN
Drug	SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A	ARHGEF12 USP34 MED18 REST ARID1A	7.68e-06	197	32	5	6909_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A	COL4A1 SEMA6D ZNF282 STAT6 PSD4	7.87e-06	198	32	5	6263_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SMARCA2 MED18 NCAPH2 REST	1.30e-04	186	32	4	3279_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 PSD4	1.41e-04	190	32	4	5237_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	SMARCA2 ARHGEF12 USP34 NCAPH2	1.41e-04	190	32	4	6998_UP
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.41e-04	190	32	4	2299_DN
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A	MED18 NCAPH2 REST PSD4	1.44e-04	191	32	4	2261_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.44e-04	191	32	4	4283_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	NAV2 ARHGEF12 REST SH3TC1	1.44e-04	191	32	4	5917_UP
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	SMARCA2 MED18 REST PSD4	1.47e-04	192	32	4	4104_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	USP34 MED18 SH3TC1 ZNF282	1.47e-04	192	32	4	3729_DN
Drug	Isosorbide dinitrate [87-33-2]; Up 200; 17uM; HL60; HT_HG-U133A	NCAPH2 SEMA6D SH3TC1 PPM1G	1.47e-04	192	32	4	2183_UP
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	NAV2 ARHGEF12 USP34 MED18	1.47e-04	192	32	4	3470_UP
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MED18 NCAPH2 STAT6 PSD4	1.49e-04	193	32	4	5985_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	USP34 MED18 NCAPH2 PSD4	1.49e-04	193	32	4	2366_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.52e-04	194	32	4	4141_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	USP34 MED18 PPM1G PSD4	1.52e-04	194	32	4	3747_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.52e-04	194	32	4	3377_DN
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	MED18 NCAPH2 REST ARID1A	1.52e-04	194	32	4	2825_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SMARCA2 NAV2 MED18 REST	1.52e-04	194	32	4	3274_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	USP34 NCAPH2 ZNF282 PSD4	1.52e-04	194	32	4	6811_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	USP34 MED18 CAMTA2 REST	1.52e-04	194	32	4	3431_DN
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	COL4A1 MED18 NCAPH2 REST	1.55e-04	195	32	4	3309_UP
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ARHGEF12 CAMTA2 NCAPH2 REST	1.55e-04	195	32	4	2820_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.55e-04	195	32	4	3269_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.55e-04	195	32	4	6129_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	SMARCA2 USP34 MED18 CAMTA2	1.59e-04	196	32	4	1629_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ARHGEF12 MED18 NCAPH2 PPM1G	1.59e-04	196	32	4	4834_DN
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	USP34 MED18 NCAPH2 PSD4	1.59e-04	196	32	4	7049_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CAMTA2 NCAPH2 ARID1A PSD4	1.62e-04	197	32	4	4751_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SMARCA2 MED18 CAMTA2 ZNF282	1.62e-04	197	32	4	3433_DN
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.62e-04	197	32	4	3300_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 SH3TC1	1.62e-04	197	32	4	2860_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	SMARCA2 ARHGEF12 USP34 PSD4	1.62e-04	197	32	4	3277_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A	ARHGEF12 MED18 CRTAC1 NCAPH2	1.62e-04	197	32	4	1408_UP
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A	COL4A1 SMARCA2 ARHGEF12 MED18	1.62e-04	197	32	4	6863_UP
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	SMARCA2 USP34 MED18 REST	1.62e-04	197	32	4	4476_DN
Drug	Iobenguane sulfate; Down 200; 10.8uM; PC3; HT_HG-U133A	ARHGEF12 USP34 MED18 CAMTA2	1.65e-04	198	32	4	7299_DN
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SMARCA2 REST SEMA6D ARID1A	1.65e-04	198	32	4	6083_DN
Drug	benserazide hydrochloride; Up 200; 10uM; SKMEL5; HG-U133A	ARHGEF12 CAMTA2 NCAPH2 REST	1.65e-04	198	32	4	631_UP
Drug	Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; PC3; HT_HG-U133A	SMARCA2 MED18 NCAPH2 PSD4	1.65e-04	198	32	4	5868_UP
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	ARHGEF12 MED18 NCAPH2 REST	1.65e-04	198	32	4	6354_UP
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A	ARHGEF12 MED18 NCAPH2 ARID1A	1.65e-04	198	32	4	6309_UP
Drug	Vidarabine [5536-17-4]; Up 200; 15uM; MCF7; HT_HG-U133A	USP34 NCAPH2 ARID1A PSD4	1.65e-04	198	32	4	7203_UP
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A	ARHGEF12 REST SEMA6D ARID1A	1.65e-04	198	32	4	6327_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A	ARHGEF12 MED18 NCAPH2 PSD4	1.65e-04	198	32	4	1411_UP
Drug	Glibenclamide [10238-21-8]; Down 200; 8uM; PC3; HT_HG-U133A	COL4A1 ARHGEF12 NCAPH2 PPM1G	1.65e-04	198	32	4	5849_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A	ARHGEF12 MED18 ZNF282 PPM1G	1.65e-04	198	32	4	7135_DN
Drug	pantogab	COL4A1 NAV2 BCL9L ARID1A CCDC157 STAT6	1.67e-04	601	32	6	ctd:C016030
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL4A1 CRTAC1 ARID1A STAT6	1.68e-04	199	32	4	6795_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SMARCA2 NCAPH2 SH3TC1 PSD4	1.68e-04	199	32	4	3344_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	USP34 NCAPH2 REST ZNF282	1.68e-04	199	32	4	3445_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A	USP34 MED18 NCAPH2 REST	1.68e-04	199	32	4	2252_DN
Drug	Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	NAV2 NCAPH2 ARID1A SH3TC1	1.68e-04	199	32	4	7414_UP
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A	ARHGEF12 USP34 MED18 PSD4	1.68e-04	199	32	4	1383_UP
Drug	Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A	ARHGEF12 CAMTA2 NCAPH2 PSD4	1.71e-04	200	32	4	2082_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	USP34 NCAPH2 REST ARID1A	1.71e-04	200	32	4	4824_DN
Drug	bromhexine	SMARCA2 RENBP	1.72e-04	14	32	2	CID000002442
Drug	3,4-PCB	AHRR STAT6	3.58e-04	20	32	2	CID000018102
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 ARID1B ARID1A	1.16e-08	5	32	3	C3281201
Disease	Coffin-Siris syndrome	SMARCA2 ARID1B ARID1A	3.29e-07	13	32	3	C0265338
Disease	normal	AHRR NCAPH2	1.70e-05	6	32	2	PATO_0000461
Disease	neuroblastoma (is_implicated_in)	ARID1B ARID1A	5.10e-05	10	32	2	DOID:769 (is_implicated_in)
Disease	alcohol use disorder (implicated_via_orthology)	SMARCA2 ARID1B ARID1A PSD4	5.75e-05	195	32	4	DOID:1574 (implicated_via_orthology)
Disease	eosinophil measurement	USP34 MED18 ZNF282	2.19e-04	108	32	3	EFO_0803540
Disease	Granulomatous Slack Skin	CARD11 ARID1A	2.60e-04	22	32	2	C0376407
Disease	Lymphoma, T-Cell, Cutaneous	CARD11 ARID1A	2.84e-04	23	32	2	C0079773
Disease	testosterone measurement	SMARCA2 DIP2B CRTAC1 ARID1B SEMA6D ARID1A METTL15	3.60e-04	1275	32	7	EFO_0004908
Disease	Sezary Syndrome	CARD11 ARID1A	3.93e-04	27	32	2	C0036920
Disease	age at menarche	SMARCA2 USP34 SEMA6D ARID1A METTL15	4.17e-04	594	32	5	EFO_0004703
Disease	gastric adenocarcinoma (is_marker_for)	ARID1A STAT6	4.23e-04	28	32	2	DOID:3717 (is_marker_for)
Disease	Bilateral Wilms Tumor	REST ARID1A	4.54e-04	29	32	2	C2930471
Disease	cortical surface area measurement	NAV2 ARHGEF12 USP34 CRTAC1 ARID1B REST SH3RF3	4.97e-04	1345	32	7	EFO_0010736
Disease	pulse pressure measurement	COL4A1 ARHGEF12 USP34 DIP2B CRTAC1 ARID1B CCDC157	6.10e-04	1392	32	7	EFO_0005763
Disease	Nephroblastoma	REST ARID1A	7.01e-04	36	32	2	C0027708
Disease	Dermatitis, Atopic	CARD11 STAT6	7.01e-04	36	32	2	C0011615
Disease	Eczema, Infantile	CARD11 STAT6	7.01e-04	36	32	2	C0086196
Disease	white matter microstructure measurement	NAV2 DIP2B CARD11 CCDC157	8.06e-04	390	32	4	EFO_0005674
Disease	Neoplasm of uncertain or unknown behavior of breast	ARID1B ARID1A	9.10e-04	41	32	2	C0496956
Disease	Breast adenocarcinoma	ARID1B ARID1A	9.10e-04	41	32	2	C0858252
Disease	childhood gender nonconformity	SMARCA2 NAV2	1.00e-03	43	32	2	EFO_0020103
Disease	sexual dimorphism measurement	DIP2B CARD11 REST ARID1A METTL15 FER1L4	1.07e-03	1106	32	6	EFO_0021796
Disease	Neuroblastoma	ARID1B ARID1A	1.19e-03	47	32	2	C0027819
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	DIP2B CRTAC1	1.30e-03	49	32	2	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	AHCYL1 ARID1B REST SEMA6D METTL15	1.60e-03	801	32	5	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Diffuse Large B-Cell Lymphoma	CARD11 STAT6	1.63e-03	55	32	2	C0079744
Disease	irritable bowel syndrome symptom measurement	NAV2 ARID1B	1.81e-03	58	32	2	EFO_0021536
Disease	parental longevity	COL4A1 SMARCA2 SEMA6D PSD4	1.92e-03	494	32	4	EFO_0007796

Protein segments in the cluster

Peptide	Gene	Start	Entry
MEDMKLQGVPMPPGD	AHRR	511	A9YTQ3
PAPLPASEMTMEDMA	CAMTA2	866	O94983
PTMGRSQGSPMDPMV	ARID1B	591	Q8NFD5
EQMMPPAQAAGPCMS	CCDC157	101	Q569K6
MTPEMPTMEPEGGLD	ARHGEF12	1361	Q9NZN5
PEPMPMSMAPITGEN	COL4A1	1526	P02462
MDLPEGPVGGPTAEM	KASH5	1	Q8N6L0
MPPQMMGGPIQASAE	ARID1A	1476	O14497
QGAPAAEPMAVPMML	RENBP	181	P51606
MGPAPMEPAQMEVAQ	REST	701	Q13127
MDIPFLGEMPAEPMT	NAXE	161	Q8NCW5
GEMEETGDMMPKGPQ	FER1L4	1046	A9Z1Z3
VMPGGMMCIVKPDGP	DIP2B	726	Q9P265
PLDMRMDGGRYPDMP	METTL15	191	A6NJ78
MEAPPVTMMPVTGGT	MED18	1	Q9BUE0
VPGFGGMQSMPMEVP	BCL9L	611	Q86UU0
MAPSADPGMSRMLPF	CRTAC1	1	Q9NQ79
MPGGGPEMDDYMETL	CARD11	1	Q9BXL7
EGMMLQEQLPMDSGP	CPHXL	326	A0A1W2PPM1
PMPTMGSTDFPQEGM	SMARCA2	56	P51531
MSMPDAMPLPGVGEE	AHCYL1	1	O43865
EMMVPGMEGKEEPGS	PPM1G	311	O15355
QMPPSDAEGDPLMNM	NAV2	2436	Q8IVL1
MMGDYRLPDHPQPME	PSD4	1	Q8NDX1
DDAMGGPVMPGNPLM	SH3TC1	291	Q8TE82
AFMLEPEGMSPMEPA	NCAPH2	191	Q6IBW4
PEGMSPMEPAGVSPM	NCAPH2	196	Q6IBW4
CPIESEMQGAMGMEP	SH3RF3	776	Q8TEJ3
PDSSMSMQLGPDMVP	STAT6	676	P42226
MAMALPMPGPQEAVV	ZNF517	1	Q6ZMY9
LLTMLMEFAGGPPGM	USP34	2606	Q70CQ2
NLMLDPMGSMSEVPP	SEMA6D	906	Q8NFY4
MAAAEPMGPAQVPMN	ZNF772	1	Q68DY9
PALRGEMAEGMPPMQ	ZNF282	41	Q9UDV7